The Randomized OPTIMAL-ACT Trial

Clinical trial NCT03772613 · COMPLETED

Trial details

NCT number: NCT03772613
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease Ischemic Heart Disease Anticoagulant-induced Bleeding Coronary Syndrome

Start date: 2019-02-08
Primary completion: 2021-10-25
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.